logo

Humanitas.itLa Ricerca

Naviga per


Laboratorio di Immunopatologia gastrointestinale

Attività di Ricerca Ricerca clinica Silvio Danese Pubblicazioni
PUBBLICAZIONI SELEZIONATE

  1. Fiorino G , Bonifacio C §, Peyrin-Biroulet L.,Minuti F, Repici A, Spinelli A, Fries W, Montorsi M, Balzarini     L, Malesci A, Danese S. Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileo-colonic Crohn’s disease. Inflamm Bow Dis, In press.
  2. Pariente B, Cosnes J, Danese S, et al. Development of the Crohn’s Disease Digestive Damage Score (CD 3S). Inflamm Bow Dis, In press.
  3. Vetrano S, Borroni E. M, Sarukhan A, Savino B, Bonecchi R, Correale C, Arena V, Fantini M, Roncalli M, Malesi A, Mantovani A, Locati M, Danese S The lympathic system control intestinal inflammation and inflammation-associated colon cancer thorugh the chemokine decoy receptor D6. Gut. 2010; 59(2):197-206
  4. Tursi A, Brandimarte G, Papa A, Giglio A, Elisei W, Giorgetti GM, Forti G, Morini S, Hassan C, Pistoia MA, Modeo ME, Rodino' S, D'Amico T, Sebkova L, Sacca' N, Di Giulio E, Luzza F, Imeneo M, Larussa T, Di Rosa S, Annese V, Danese S, Gasbarrini A. Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study. Am J Gastroenterol. 2010 Jun 1. [Epub ahead of print]
  5. Laverny G, Penna G, Vetrano S, Correale C, Nebuloni M, Danese S, Adorini L. Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease. Immunol Lett. 2010 Jun 15;131(1):49-58 .
  6. Rutella S, Vetrano S, Correale C, Graziani C, Sturm A, Spinelli A, De Cristofaro R, Repici A, Malesci A, Danese S. Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature. J Cell Mol Med . 2010 Feb 16. [Epub ahead of print]
  7. Scaldaferri F, Vetrano S, Sans M, Arena V, Straface G, Stigliano E, Repici A, Sturm A, Malesci A, Panes J, Yla-Herttuala S, Fiocchi C, Danese S. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. Gastroenterology. 2009 Feb;136:585-95.e5.
  8. Scaldaferri F, Sans M, Vetrano S, Correale C, Arena V, Pagano N, Rando G, Romeo F, Potenza AE, Repici A, Malesci A, Danese S. The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease. Eur J Immunol. 2009;39:290-300.
  9. Angelucci E, Orlando A, Ardizzone S, Guidi L, Sorrentino D, Fries W, Astegiano M, Sociale O, Cesarini M, Renna S, Cassinotti A, Marzo M, Quaglia A, Sergi MD, Simondi D, Vernia P, Malesci A, Danese S. Internet use among inflammatory bowel disease patients: an Italian multicenter survey. Eur J Gastroenterol Hepatol. 2009 Sep;21:1036-41.
  10. de la Motte C, Nigro J, Vasanji A, Rho H, Kessler S, Bandyopadhyay S, Danese S, Fiocchi C, Stern R. Platelet-derived hyaluronidase 2 cleaves hyaluronan into fragments that trigger monocyte-mediated production of proinflammatory cytokines. Am J Pathol. 2009 Jun;174:2254-64
  11. Malesci A, Angelucci E, Bonifacio C, Sociale O, Omodei P, Repici A, Balzarini L, Danese S. Closure of perianal fistula using adalimumab in a Crohn's disease patient naive to antitumor necrosis factor alpha antibodies. Inflamm Bowel Dis. 2009 Jun;15:814-5.
  12. Vetrano S, Rescigno M, Cera MR, Correale C, Rumio C, Doni A, Fantini M, Sturm A, Borroni E, Repici A, Locati M, Malesci A, Dejana E, Danese S. Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease. Gastroenterology. 2008 Jul;135:173-84.
  13. Paclik D, Danese S, Berndt U, Wiedenmann B, Dignass A, Sturm A. Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle. PLoS One. 2008 Jul 9;3:e2629.
  14. Vetrano S, Correale C, Borroni EM, Pagano N, Savino B, Locati M, Malesci A, Repici A, Danese S. Colifagina, a novel preparation of 8 lysed bacteria ameliorates experimental colitis. Int J Immunopathol Pharmacol. 2008 Apr-Jun;21:401-7.
  15. Danese S, Mocciaro F, Guidi L, Scribano ML, Comberlato M, Annese V, Colombo E, Stefanelli T, Marzo M, Vangeli M, Pulitano' R, Manca A, Armuzzi A, Malesci A, Prantera C, Cottone M. Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients refractory or intolerant to infliximab: a real-life multicenter experience of compassionate use. Inflamm Bowel Dis. 2008 Aug;14:1168-70.
  16. Repici A, De Caro G, Luigiano C, Fabbri C, Pagano N, Preatoni P, Danese S, Fuccio L, Consolo P, Malesci A, D'Imperio N, Cennamo V. WallFlex colonic stent placement for management of malignant colonic obstruction: a prospective study at two centers. Gastrointest Endosc. 2008 Jan;67:77-84.
  17. Paclik D, Berndt U, Guzy C, Dankof A, Danese S, Holzloehner P, Rosewicz S, Wiedenmann B, Wittig BM, Dignass AU, Sturm A. Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice.  J Mol Med. 2008 Dec;86:1395-406.
  18. Repici A, Barbon V, De Angelis C, Luigiano C, De Caro G, Hervoso C, Danese S, Preatoni P, Pagano N, Comunale S, Pennazio M, Rizzetto M. Acute small-bowel perforation secondary to capsule endoscopy. Gastrointest Endosc. 2008 Jan;67:180-3.
  19. Danese S, Stefanelli T, Omodei P, Zatelli S, Bonifacio C, Balzarini L, Repici A, Malesci A. Successful treatment of fistulizing Crohn's disease with certolizumab pegol. Inflamm Bowel Dis. 2008 Feb;14:292-3.

STRUMENTI UTILI

Mail

Stampa

Istituto Clinico Humanitas Humanitas Gavazzeni Humanitas Centro Catanese
di Oncologia
Humanitas Mater Domini Clinica Cellini
Il giornale della salutewww.humanitasalute.it Check up e Second Opinionwww.humanitasonline.com Fondazione per la ricercawww.humanitasricerca.org Fondazione Humanitaswww.fondazionehumanitas.it Fondazione Arielwww.fondazioneariel.it